1	IL-7	IL-7	_	_	_	_	_	_	_
2	reconstitutes	reconstitute	_	_	_	_	_	_	_
3	multiple	multiple	_	_	_	_	_	_	_
4	aspects	aspect	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	v-Abl-mediated	v-abl-mediated	_	_	_	_	_	_	_
7	signaling	signaling	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	mechanism	mechanism	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	which	which	_	_	_	_	_	_	_
5	early	early	_	_	_	_	_	_	_
6	lymphoid	lymphoid	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	are	be	_	_	_	_	_	_	_
9	selectively	selectively	_	_	_	_	_	_	_
10	transformed	transform	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	v-Abl	v-abl	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	currently	currently	_	_	_	_	_	_	_
15	unknown	unknown	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Previous	previous	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	constitutive	constitutive	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	IL-4	il-4	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	IL-7	il-7	_	_	_	_	_	_	_
11	signaling	signaling	_	_	_	_	_	_	_
12	pathways	pathway	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	measured	measure	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	Janus	Janus	_	_	_	_	_	_	_
20	protein	protein	_	_	_	_	_	_	_
21	kinase	kinase	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	JAK)1	JAK)1	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	JAK3	JAK3	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	STAT5	STAT5	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	STAT6	STAT6	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	pre-B	pre-b	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	transformed	transform	_	_	_	_	_	_	_
36	by	by	_	_	_	_	_	_	_
37	v-Abl	v-abl	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	determine	determine	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	activation	activation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	these	these	_	_	_	_	_	_	_
7	cytokine	cytokine	_	_	_	_	_	_	_
8	signaling	signaling	_	_	_	_	_	_	_
9	pathways	pathway	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	v-Abl	v-abl	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	important	important	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	cellular	cellular	_	_	_	_	_	_	_
17	events	event	_	_	_	_	_	_	_
18	induced	induce	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	Abelson	Abelson	_	_	_	_	_	_	_
22	murine	murine	_	_	_	_	_	_	_
23	leukemia	leukemia	_	_	_	_	_	_	_
24	virus	virus	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	effects	effect	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	IL-4	il-4	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	IL-7	il-7	_	_	_	_	_	_	_
32	on	on	_	_	_	_	_	_	_
33	pre-B	pre-b	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	transformed	transform	_	_	_	_	_	_	_
36	with	with	_	_	_	_	_	_	_
37	a	a	_	_	_	_	_	_	_
38	temperature-sensitive	temperature-sensitive	_	_	_	_	_	_	_
39	v-Abl	v-abl	_	_	_	_	_	_	_
40	mutant	mutant	_	_	_	_	_	_	_
41	were	be	_	_	_	_	_	_	_
42	examined	examine	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	Whereas	whereas	_	_	_	_	_	_	_
2	IL-4	il-4	_	_	_	_	_	_	_
3	had	have	_	_	_	_	_	_	_
4	little	little	_	_	_	_	_	_	_
5	or	or	_	_	_	_	_	_	_
6	no	no	_	_	_	_	_	_	_
7	effect	effect	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	IL-7	IL-7	_	_	_	_	_	_	_
10	delayed	delay	_	_	_	_	_	_	_
11	both	both	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	apoptosis	apoptosis	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	cycle	cycle	_	_	_	_	_	_	_
17	arrest	arrest	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	occur	occur	_	_	_	_	_	_	_
20	upon	upon	_	_	_	_	_	_	_
21	v-Abl	v-abl	_	_	_	_	_	_	_
22	kinase	kinase	_	_	_	_	_	_	_
23	inactivation	inactivation	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	IL-7	IL-7	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	delayed	delay	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	decreases	decrease	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	levels	level	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	c-Myc	c-myc	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	Bcl-2	bcl-2	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	Bcl-xL	Bcl-xL	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	occur	occur	_	_	_	_	_	_	_
18	upon	upon	_	_	_	_	_	_	_
19	loss	loss	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	v-Abl	v-abl	_	_	_	_	_	_	_
22	kinase	kinase	_	_	_	_	_	_	_
23	activity	activity	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	IL-7	IL-7	_	_	_	_	_	_	_
2	did	do	_	_	_	_	_	_	_
3	not	not	_	_	_	_	_	_	_
4	maintain	maintain	_	_	_	_	_	_	_
5	v-Abl-mediated	v-abl-mediated	_	_	_	_	_	_	_
6	differentiation	differentiation	_	_	_	_	_	_	_
7	arrest	arrest	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	pre-B	pre-b	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	RAG	RAG	_	_	_	_	_	_	_
19	gene	gene	_	_	_	_	_	_	_
20	transcription	transcription	_	_	_	_	_	_	_
21	was	be	_	_	_	_	_	_	_
22	unaffected	unaffected	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	IL-7	IL-7	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	identify	identify	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	potential	potential	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	IL-7	il-7	_	_	_	_	_	_	_
9	signaling	signaling	_	_	_	_	_	_	_
10	pathways	pathway	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	transformation	transformation	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	v-Abl	v-abl	_	_	_	_	_	_	_
15	while	while	_	_	_	_	_	_	_
16	demonstrating	demonstrate	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	combination	combination	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	IL-4	il-4	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	IL-7	il-7	_	_	_	_	_	_	_
24	signaling	signaling	_	_	_	_	_	_	_
25	cannot	cannot	_	_	_	_	_	_	_
26	substitute	substitute	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	an	an	_	_	_	_	_	_	_
29	active	active	_	_	_	_	_	_	_
30	v-Abl	v-abl	_	_	_	_	_	_	_
31	kinase	kinase	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	transformed	transform	_	_	_	_	_	_	_
34	pre-B	pre-b	_	_	_	_	_	_	_
35	cells	cell	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

